44th Annual UNC Lineberger Scientific Symposium
UNC Lineberger Comprehensive Cancer Center will host its 44th annual scientific symposium on March 18-19, 2020, at the William and Ida Friday Center for Continuing Education in Chapel Hill, North Carolina.
Please contact Elneter “Melissa” Stroud Mack, Operations Manager, Office of Director, 919-966-0509, emstroud@med.unc.edu, if you have questions about the symposium.
“The Yin-Yang of Immunity in Cancer”
Organizers
Jenny Ting, PhD, Lishan Su, PhD, and Albert S. Baldwin, PhD
Confirmed Speakers
Victor Engelhard, PhD
University of Virginia
“Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity”
Dimtry Gabrilovich, MD-PhD
The Wistar Institute
“Regulation of tumor progression by myeloid-derived suppressor cells. Servant of all masters”
Tom Gajewski, MD
University of Chicago
“Mechanisms of immunotherapy response versus resistance”
Tak Mak, PhD
Princess Margaret Hospital in Toronto, University of Toronto
“Beyond immune checkpoint blockade: emerging strategies”
Jennifer Martinez, PhD
National Institute of Environmental Health Sciences
“The double-edged sword of non-canonical autophagy”
Florencia McAllister, MD
MD Anderson Cancer Center
“The role of the gut-tumor microbial axis in modulating the immune response”
Yuliya Pylayeva-Gupta, PhD
University of North Carolina Lineberger Comprehensive Cancer Center
“Tumor immune modulation by B lymphocytes”
Arlene Sharpe, MD, PhD
Harvard Medical School
“The biology behind PD-1 checkpoint blockade”
Lishan Su, PhD
University of North Carolina Lineberger Comprehensive Cancer Center
The pDC/IFN axis in chronic virus infection and cancer immunotherapy”
Jenny Ting, PhD
University of North Carolina Lineberger Comprehensive Cancer Center
“Innate immunity, microbiota and cancer”
Giorgio Trinchieri, MD
National Cancer Institute
“Cancer and the Microbiome”
Mary Jo Turk, PhD
Dartmouth University School of Medicine
“Generating host-wide resident memory T cell responses to cancer”
Yisong Wan, PhD
University of North Carolina Lineberger Comprehensive Cancer Center
“TGF-beta signaling in T cell function and tumor immunity”
Irving Weissman, MD
Stanford Institute of Stem Cell Biology and Regenerative Medicine, Stanford University
“Normal and neoplastic stem cells: Therapies for autoimmune and deficiency disease and targets for immunotherapies”
Weiping Zou, MD-PhD
University of Michigan
“Metabolic impact on cancer immunity and therapy“